AU3190593A - Molecules for iontophoretic delivery - Google Patents

Molecules for iontophoretic delivery

Info

Publication number
AU3190593A
AU3190593A AU31905/93A AU3190593A AU3190593A AU 3190593 A AU3190593 A AU 3190593A AU 31905/93 A AU31905/93 A AU 31905/93A AU 3190593 A AU3190593 A AU 3190593A AU 3190593 A AU3190593 A AU 3190593A
Authority
AU
Australia
Prior art keywords
molecules
iontophoretic delivery
iontophoretic
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU31905/93A
Other versions
AU665046B2 (en
Inventor
Randal A. Hoke
Burton H. Sage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vyteris Inc
Original Assignee
Vyteris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25239567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU3190593(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vyteris Inc filed Critical Vyteris Inc
Publication of AU3190593A publication Critical patent/AU3190593A/en
Application granted granted Critical
Publication of AU665046B2 publication Critical patent/AU665046B2/en
Assigned to VYTERIS, INC. reassignment VYTERIS, INC. Alteration of Name(s) in Register under S187 Assignors: BECTON DICKINSON & COMPANY
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Electrotherapy Devices (AREA)
AU31905/93A 1992-01-22 1993-01-20 Molecules for iontophoretic delivery Ceased AU665046B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82373092A 1992-01-22 1992-01-22
US823730 1992-01-22

Publications (2)

Publication Number Publication Date
AU3190593A true AU3190593A (en) 1993-07-29
AU665046B2 AU665046B2 (en) 1995-12-14

Family

ID=25239567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31905/93A Ceased AU665046B2 (en) 1992-01-22 1993-01-20 Molecules for iontophoretic delivery

Country Status (7)

Country Link
US (1) US5494679A (en)
EP (1) EP0552878B2 (en)
JP (1) JP2506543B2 (en)
AU (1) AU665046B2 (en)
CA (1) CA2087087C (en)
DE (1) DE69323913T2 (en)
ES (1) ES2130219T3 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956032B1 (en) * 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
GB9312351D0 (en) * 1993-06-16 1993-07-28 Ici Plc Thermal transfer printing dyesheet
US5843015A (en) * 1993-12-28 1998-12-01 Becton Dickinson And Company Molecules for iontophoretic delivery
US5505715A (en) * 1994-02-25 1996-04-09 Bristol-Myers Squibb Company Iontophoretic transdermal delivery of deoxyspergualin compounds
JPH09511927A (en) * 1994-04-18 1997-12-02 ザ、プロクター、エンド、ギャンブル、カンパニー Iontophoretic delivery of bisphosphonates to alveolar bone
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
IT1285405B1 (en) 1995-06-06 1998-06-03 Alza Corp MODIFICATION OF POLYPEPTIDE DRUGS TO INCREASE FLOW BY ELECTROTRANSPORT.
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
US5961483A (en) * 1996-06-19 1999-10-05 Sage; Burton H. Iontophoretic delivery of cell adhesion inhibitors
WO1998051324A1 (en) 1997-05-14 1998-11-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Peptide parathyroid hormone analogs
EP0898962A1 (en) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Transdermal patches and methods for inactivating skin proteases
US6375990B1 (en) 1997-10-09 2002-04-23 Emory University Method and devices for transdermal delivery of lithium
JP2001522793A (en) * 1997-11-12 2001-11-20 アルザ コーポレイション Buffered drug formulations for transdermal electrotransport delivery
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6148231A (en) * 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6477410B1 (en) 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US6792306B2 (en) * 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
CH696701A5 (en) * 2001-12-18 2007-10-15 Hoffmann La Roche A method for testing an agent for its ability to inhibit heparanase activity.
JP5241517B2 (en) * 2007-02-06 2013-07-17 久光製薬株式会社 Microneedle device for allergy diagnosis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5314072B2 (en) * 1973-09-29 1978-05-15
DE3326473A1 (en) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt PHARMACEUTICAL AGENT FOR TREATING THE DIABETES MELLITUS
US4585652A (en) * 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US5042975A (en) * 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
JPS63102768A (en) * 1986-10-20 1988-05-07 山之内製薬株式会社 Novel plaster structure for iontophoresis
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US4965343A (en) * 1988-01-28 1990-10-23 Hoffmann-La Roche Inc. Method of peptide synthesis
GB8806893D0 (en) * 1988-03-23 1988-04-27 Unilever Plc Cosmetic composition
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
IT1244030B (en) * 1989-12-21 1994-06-28 Elan Corp Plc TWO-PART DEVICE FOR THE CONTROLLED ADMINISTRATION OF AN INGREDIENT
JPH04224770A (en) * 1990-12-26 1992-08-14 Teijin Ltd Apparatus for iontophoresis
DK10191D0 (en) * 1991-01-22 1991-01-22 Novo Nordisk As HIS UNKNOWN PEPTIDES
US5203768A (en) * 1991-07-24 1993-04-20 Alza Corporation Transdermal delivery device

Also Published As

Publication number Publication date
ES2130219T3 (en) 1999-07-01
DE69323913D1 (en) 1999-04-22
EP0552878B2 (en) 2002-11-20
EP0552878A2 (en) 1993-07-28
AU665046B2 (en) 1995-12-14
JPH05345727A (en) 1993-12-27
US5494679A (en) 1996-02-27
CA2087087C (en) 2000-07-18
CA2087087A1 (en) 1993-07-23
JP2506543B2 (en) 1996-06-12
DE69323913T2 (en) 1999-10-14
EP0552878B1 (en) 1999-03-17
EP0552878A3 (en) 1993-08-25

Similar Documents

Publication Publication Date Title
AU3190593A (en) Molecules for iontophoretic delivery
AU3050892A (en) Delivery system
AU669350B2 (en) Electrode
AU5975694A (en) Electrotherapeutic apparatus
AU3284193A (en) Interface for iontophoresis
AU3825595A (en) Improved iontophoretic drug delivery device
AU7247894A (en) Liquid delivery apparatus
AU4380593A (en) Reference electrode
AU5741294A (en) Impelling apparatus
AU656651B2 (en) Corpuscle-detecting apparatus
AU4348493A (en) Inhaler
AUPM885894A0 (en) Therapeutic molecules
AU5258493A (en) Feed pump
AU5165993A (en) Pp14-based therapy
AU1687997A (en) Molecules for iontophoretic delivery
AU4365593A (en) Unit for treating liquid
AU4928193A (en) Stop solution
AU4342093A (en) Controlled delivery apparatus
AU4566593A (en) Double-sheath filled-wire electrode
AU3219493A (en) Pump
AU668189B2 (en) Aromatherapy apparatus
AU660764B2 (en) Invertile dispenser
AU2879797A (en) Vapourizer apparatus
AU5332894A (en) Animal-feeding apparatus
AU4791096A (en) Delivery system

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: VYTERIS, INC.

Free format text: FORMER OWNER WAS: BECTON, DICKINSON AND COMPANY

MK14 Patent ceased section 143(a) (annual fees not paid) or expired